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Cantor  and  Asofsky  (1,  2)  demonstrated  that  the  inoculation  of  mixtures  of 
peripheral  lymph node  (LN) 1 and  thymus cells  from parental  mice into F1 hybrid 
recipients  would produce graft-vs.-host  (GVH)  reactions  (3)  greater  than  the  sum 
expected from separate reactivities of the two cell populations alone. Studies with cells 
from thymectomized donors (2) or cells pretreated with antitheta serum (4) indicated 
that both cell populations involved in this "synergy" were thymus derived. The dis- 
tribution  of  the  populations  among different  lymphoid  "compartments"  and  their 
in vivo susceptibilities to heterologous antithymocyte serum (ATS) suggested that the 
two  T-cell  types had  different migratory patterns  (2).  Those present  in  excess  in 
thymus and spleen  (T1 cells)  appeared  to recirculate slowly and to be precursors of 
the cells  which inflict immunologic injury in the GVH reaction  (2).  This ability  to 
inflict injury could be amplified by interaction with rapidly recirculating (T~) lympho- 
cytes from peripheral blood and lymph nodes. Additional evidence that the synergiz- 
ing subpopulations resided chiefly in different lymphoid organs was based upon GVH 
reactivity  of LN and  spleen  cells  from lethally  irradiated  mice reconstituted  with 
syngeneic spleen cells  (5). 
The  mixed  lymphocyte culture  reaction  (MLR)  may well  represent  an in vitro 
correlate of the early phase of the GVH reaction  (3).  Synergistic in vitro responses 
between  thymus-dependent  subpopulations  in  MLR  and  also  in  the  cell-mediated 
lymphocytotoxic reaction have recently been described in several laboratories  (6-8). 
In the present study of the "one-way" MLR we describe various further parameters 
of the  synergy obtained  when responding  LN  and  spleen  cells  are  combined with 
thymus cells or with each other. Our data lend additional support to the concept that 
the same two cell types demonstrating synergy in the GVH reaction (T1 and T2 cells) 
also synergize in the MLR. 
Materials and Methods 
Animals.--4- to 8-mo old male C57BL/6J (H-2b), 3- to 10-mo old male CBA/J (H-2k), 
6- to 7-mo old male (C57BL/6J  X  129) F1 hybrid,  and 4- to 6-mo old male (C57BL/6J  X 
CBA/J)F1 hybrid  mice were used. 
* Supported  by National  Cancer Institute grant CA12788. 
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1  Abbreviations used in this papefl ATS, antithymocyte serum; B6, C57BL/6J mice; GVH, 
graft-vs.-host;  LD, lymphocyte defined; LN, lymph node; MLR, mixed lymphocyte culture 
reaction; NRS, normal rabbit serum; SD, serologically defined. 
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Cell Suspensions.--Suspeusious  from  thymus,  spleen,  and  lymph  nodes  (pooled  from 
inguinal, axillary, brachial, and submandibular  nodes)  were prepared  by teasing in a  small 
amount  of  medium.  Hepes-buffered  medium  RPMI-1640  (Grand  Island  Biological  Co., 
Grand island, N. Y.) with 1% antibiotic-antimycotic mixture (Gibco) and 7% pooled heat- 
inactivated human serum was employed (9). Debris was removed by sedimentation, and the 
cells were washed twice and resuspended in medium. Erythrocytes in spleen suspensions were 
lysed with ammonium-chloride solution  (10).  All suspensions  were passed  through  no.  27 
gauge needles, examined for viability via trypan blue exclusion,  and adjusted to the desired 
concentration of viable cells. 
MLR.--Stimulating  cells consisted  of CBA spleen cells for  the allogeneic reaction  and 
syngeneic cells for controls. 15 X  10  e viable stimulating eells/ml were incubated in a 50 #g/ml 
solution of mitomycin-C for 20 min at 37°C in a  water bath,  followed by three washes in 
medium. The MLR itself was carded out in titer plates  (220/24A Disco "U" plates, Scientific 
Educational Products Corp., New York). 0.1 ml of stimulating and 0.1 ml  of responding cell 
suspensions  were placed in each cup and the plates sealed with clear mylar covers  (35PSM, 
Linbro Chemical Co., New Haven, Conn.). After 48 h at 37°C, 3/~Ci [aHH]thymidine (Schwarz/ 
Mann Div., Becton, Dickinson & Co. sp act 1.9 mCi/mmol) in 0.1-ml serum-free medium was 
added to each cup and incubation continued for another 16 h. The reaction was  stopped  by 
chilling to 4°C, the mixtures transferred to centrifuge tubes, washed twice in 50/0 trichloracetic 
acid, once in methanol, and transferred to counting vials. After evaporation of methanol,  10 
ml of scintillation liquid (5 g 2,5-diphenyloxazole and  100 mg  1,4-bis[2-(5-phenyloxazolyl)]- 
benzene/liter of toluene containing 3%  "solubilizer" [Nuclear-Chicago Corp.,  Des  Plaines, 
Ill.l) was added. The vials were allowed to stand for 12 h and the [SH]thymidine  uptake  was 
measured  in a  Beckman model LS-25 liquid  scintillation counter  (Beckman  Instruments, 
Inc., Fullerton, Calif.). Control values from syngeneic combinations were subtracted from the 
experimental (allogeneic)  values. All tests were done in quadruplicate and means and  standard 
errors computed. Statistical comparisonswere done via Student's t test. When the "expected" 
was compared with the observed value, the SE of the observed value was assumed also for the 
expected one: this introduced a slight conservative bias in the probability values. 
In Vitro Treatment with Anti-O Serum and Complements--Anti-O serum was produced by 
injections of AKR mice with CBA thymocytes  (10). The activity could be completely ab- 
sorbed with mouse brain. For in vitro treatment, 25 X  106 living LN cells/ml were incubated 
in 0.4 ml of anti-0 serum or in normal AKR serum for 30 rain at 37°C, then for 30 rain at 37°C 
with 0.6 rul of complement added. The serum of New Zealand rabbits previously screened for 
low natural  toxicity for mouse thymus and  spleen cells and  also preabsorbed  at 4°C ,with 
lymphoid cells was employed as the complement source (11). 
A TS.--ATS was prepared  by immunizing young adult New Zealand white rabbits  with 
C57BL/6J  (B6)  thymocytes according to Levey and  Medawar  (12).  It was inactivated at 
56°C for 30 rain and absorbed with 1/20th vol of washed B6 erythrocytes. 
Irradiation.--Exposure of mice to 1,200 R whole body irradiation was done with a Picker 
Vanguard machine (Picker Corp., Cleveland, Ohio) under conditions of 280 kV, 20 mA, half- 
value layer 1.28 mm copper, at a  distance of 52 cm and an administered  dose rate of 137 
R/rain. 
RESULTS 
MLR  Standard  Curves for  Thymus Cells,  LN Cells,  and  a  Thymus-LN  Cell 
Mixture.--The  reactivities  of  different  concentrations  of  responding  thymus 
and LN cells from B6 mice in the standard  MLR  are shown in Fig. 1. Stimulat- 
ing  cells  consisted  of mitomycin-treated  CBA  spleen  cells at  a  constant  con- 
centration of 8  X  106 viable cells/ml. Hence the ratio of responding to stimulat- 
ing cells was  allowed to  increase  with  increasing  concentration  of responding 1490  SYNERGY  IN  THE  MIXED  LYMPHOCYTE  REACTION 
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FIG. 1.  [SH]thymidine  uptake in cpm of thymocytes, LN cells, and a mixture of 80% thy- 
mocytes and 20% LN cells from 6-too old B6 mice plotted  against concentration  of respon- 
ding cells. The expected reactivity  for the thymus (Thy)-LN mixture was constructed using 
the reactivity curves for equivalent numbers of thymocytes and LN cells. The sum of cpm 
values of the participating  partner  ceils was significantly less than  the  actually  observed 
[3H]thymidine uptake of the mixture (shown at two concentrations).  The vertical bars in this 
and all further figures represent SE. 
cells. [3H]thymidine uptake was plotted against the concentration of responding 
cells.  The reactivity  curves are  consistent  with  a  linear  relationship  between 
thymidine uptake and responding cell concentration over much of the curves. 
The LN cells were 40-50 times more active than thymus cells. The reactivity 
of a mixture of thymus cells and LN cells in a 4:1 ratio was measured at two 
concentrations (Fig. 1) and was four to five times  greater  than  expected,  rep- 
resenting  "synergy" in the MLR (P  <  0.01  at  the  concentration  of  8-10 s 
cells/ml). The expected [3H]thymidine uptake was calculated by summing the 
separate  reactivities  of  thymocytes  and  LN  cells  at  the  corresponding  cell 
concentrations. Pretreatment  of either LN or thymus cells with  mitomycin-C 
abolished synergy. 
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gistic Activity of LN Cells and Thymocytes.--LN-cell  suspensions from B6 mice 
plus  complement were incubated  in vitro either with  AKR  anti-0  serum  at 
different dilutions or in  1:4 diluted normal AKR control serum. The suspen- 
sions were washed and the LN cells set up in the MLR either alone or with 
added B6 thymocytes at a ratio of 1:4. Relatively low concentrations of anti-0 
(1 : 128) abolished the capability of LN cells both to respond and to synergize 
(Table I). 
The Effect of Prior  Treatment with A TS on the Capacity of LN Cells, Spleen 
Cells, and  Thymocytes to React in MLR--Lymphoid  cells  were obtained from 
8-mo old  (B6  X  129)Fx  females which  had received intraperitoneally either 
0.75 or 0.075 ml of ATS 3 days previously. Their reactivities were compared to 
TABLE I 
MLR of LN cells and Thymus (Thy)-LN Cell Mixtures before and after 
Treatment  with Anti-O  Serum* 
Reactants 
LN 
Measured value 
%  activity compared 
to untreated  cells 
Thy-LN mixture 
Measured value 
%  activity  compared 
to untreated  cells 
Reactivity 
of 
untreated 
cells 
65,9634-6,771 
17,8074-5,322 
Reactivity after treatment with anti-0 serum of the indicated dilutions 
1 
786-4-27~ 
1.1 
4,3054-165 
24.1 
2564-276 
1.9 
9374-482 
5.2 
505+55 
0.7 
3,810:h1,072 
21.4 
1 
4,315+1,1q 
6.5 
2,8754-918 
16.1 
1  1 
80,6104-13,68£  77,3514-6,683 
122  117 
21,3114-1,892  17,5364-3,285 
120  99 
*Values are expressed as cpm 4- SE. Treatment  of the LN cells with anti-0  in a  dilution  of 1:128 or lower greatly 
reduced or abolished b~th their direct reactivity and their ability to synergize with thymocytes. Normal AKR serum at 
a dilution of 1:4 had a  slight inhibitory effect upon the reaction but none at higher dilutions. The Thy-LN mixture was 
at a  4:1 ratio. 
lymphoid cells from control animals treated with normal rabbit serum (NRS). 
Both doses of ATS decreased the reactivity of LN cells by 30-50 %  (Figs.  2 
and 3), whereas the reactivity of spleen cells was decreased only by the higher 
dose. A paradoxical effect on thymus cells of animals treated with the highest 
ATS  dose  was  observed.  The  reactivity  increased  two  to  three-fold.  This 
observation of a reciprocal effect on thymocytes and spleen cells parallels Can- 
tor's and Asofsky's findings on the effect of ATS on the GVH reaction of cells 
derived from these sources (13). 
LN cells obtained from mice pretreated with 0.075, 0.25, and 0.75 ml ATS 
showed much less [3H]thymidine uptake in combination with normal thymo- 
cytes than  did LN  cells from NRS-treated  animals,  i.e.,  ATS  decreased or 
abolished the ability of LN cells to synergize with thymocytes (Fig. 4). 
Reactivities of LN and Spleen Cells from Irradiated Mice, and from Irradiated 
Mice Reconstituted with Syngeneic Spleen Cells.--24  (B6  X  129)F1  male mice 1492  SYN'ERGY  IN  THE  MIXED  LYMPHOCYTE  REACTION 
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FIGS. 2 and 3.  MLR of LN cells, Spl cells (Spl), and thymocytes of NRS- and ATS-treated 
8-too old B6 mice at different concentrations of responding cells.  In Fig. 2 the animals were 
treated with 0.075  ml NRS  or ATS 3  days before the test, in Fig.  3 with 0.75 ml.  At the 
higher dose ATS exerted a depressing effect upon MLR of LN cells and spleen cells; however, 
at the lower dose only the reactivity of LN cells was depressed. Thymocytes demonstrated a 
paradoxical pattern. Only the higher ATS dose influenced their reactivity which was increased 
two- to threefold. 
5-mo old were irradiated with 1,200 R. 2 h later 10 of these were injected via the 
tail vein with 100 X  l0  s spleen cells from 5-too old syngeneic males. The MLR 
of cells from spleen and LN of both irradiated and irradiated spleen cell-recon- 
stituted groups were measured 20 h  after irradiation,  and compared to cells 
from untreated  animals.  Irradiation  essentially  abolished  the  reactivities of 
both LN and spleen cells.  The irradiated reconstituted group regained some 
reactivity, about 17 % for LN and for spleen cells about 10 %  of that of cells 
from normal animals. Reconstitution thus resulted in populations in both LN 
and spleen with impaired ability to react in MLR. 
LN cells from irradiated but not reconstituted animals possessed little or no 
capacity to synergize with normal thymocytes (Fig. 5). The LN cells from Jr- W.  TITTOR,  M.  GERBASE-DELIMA,  AND  R.  L.  WALFORD  1493 
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radiated spleen cell-reconstituted mice did synergize with thymocytes. By con- 
trast,  while normal  spleen cells participated well in synergy, the spleen cells 
from irradiated spleen cell-reconstituted mice clearly did not synergize when 
mixed  with  normal  thymocytes. Hence,  irradiation  and  reconstitution  with 
spleen cells resulted in two lymphoid populations (in LN and spleen), neither 
of which reacted well by itself in the MLR, and only one of which (from LN) 
showed good synergistic activity in combination with thymocytes (Fig. 5). 
Reactivities of Mixtures of Normal  Spleen  and LN Cells, and of Spleen  and 
LN Cells from  Irradiated  Animals with  and  without  Reconstitution  by Spleen 
Cells.--The  response  of  a  normal  spleen-LN-cell  mixture  was  significantly 
elevated  compared  to  expected values,  demonstrating  synergy among  these 
cell  populations  (Fig.  6).  Mixtures  of spleen  and  LN  cells  from  irradiated 
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FIG. 6.  MLR of 4:1  mixtures of normal SpI cells with normal LN cells, of SpI-R and 
LN-R cells from mice, and of Spl-RS and LN-RS cells from mice. The hatched columns repre- 
sent the expected values. 
animals were nonreactive; however, mixtures from irradiated spleen cell-recon- 
stituted animals showed some evidence of synergy, although the total response 
was only 16 to 28 % of that of normal spleen cells. These results were obtained 
with cells from (B6 X  129)F1 hybrid mice. A mixture of normal spleen and LN 
cells from B6 mice did not manifest synergy, even though (Fig. 1) thymus and 
LN cells of this strain do synergize. 
DISCUSSION 
Our results confirm and extend prior observations that two thymus-depend- 
ent cell populations interact synergistically in the MLR (6, 8). The interaction W. TITTOR, M. GERBASE-DELIMA,  AND  R. L. WALFORD  1495 
can be demonstrated at various ratios of total responding to constant stimulator 
cell numbers (Fig.  1),  also when the total number of responding cells is held 
constant but the ratio of the T-cell subpopulations allowed to vary (8), or when 
the concentrations per ml of both responding and stimulating cells are allowed 
to increase (8). Synergy in the MLR is clearly analogous to that described by 
Cantor and Asofsky and coworkers  (1,  2,  5)  using  the  GVH reaction as  an 
indicator system. They described so-called precursor T1 cells in the thymus and 
spleen of Balb/C mice. The GVH reactivity attributed to these T1 cells could 
be increased by interaction with so-called amplifier or T2 cells from peripheral 
blood .or lymph nodes. It is pertinent to state in what ways the synergy we 
observed in MLR is similar to that described for the GVH reaction, and whether 
any apparent differences exist. 
Similarities may first be emphasized. Our experiment using combinations of 
thymocytes and LN cells in which either one of the populations consisted of F1 
hybrid cells derived from mice of the B6-responding strain and the CBA-stimu- 
lating strain indicated that in the MLR model (8), just as in the GVH model 
(1), both responding populations must be allogeneic to the stimulating cells to 
participate in  synergy. Also,  synergy was  not  observed if either responding 
cell population was inactivated, via freezing and thawing by Cantor et al. (14), 
or in our experiments by pretreatment with mitomycin-C. 
Cantor (4) demonstrated that both amplifier (T2) and precursor (T1) cells involved 
in synergy in the GVH reaction were 0 (q-) cells, and that normal LN cells contained 
both types of cells, although T~ >> T1. The amplifier activity of the LN cells was 
slightly less susceptible to low doses of anti-0 serum than was the overall GVH reac- 
tivity. In our MLR experiments we noted that treatment of LN cells with increasing 
concentrations of anti-0 resulted  in loss of both MLR responding  and  synergizing 
activities concurrently (Table I).  Since different  mouse  strains and  test situations 
were being employed, we do not regard this lack of a differential effect of anti-0 serum 
in MLR as necessarily a significant difference. 
In  the  GVH model  the  spleen  appeared  to  contain both  T1 and  T2 cells 
(T1 >> T2), and these showed different migratory patterns when injected into 
lethally irradiated mice (5). T1 cells preferably went to the spleens of the ir- 
radiated mice and T2 cells into the recirculating lymphocyte pool, which in- 
cluded the lymph nodes. Thus, the spleen cells from lethally irradiated spleen 
cell-reconstituted mice should represent a pure Tl-cell population and LN cells 
a  pure T~-cell population. Therefore, the LN cells but not the spleen cells of 
reconstituted mice should synergize with normal thymocytes. This was exactly 
what we obtained in our MLR model, as shown in Fig. 5. Spleen cells of normal 
mice of the  appropriate  strain  synergize with  thymocytes. Thus,  the spleen 
contains two subpopulations active in both GVH reaction and MLR and these 
demonstrate similar migratory patterns upon injection into irradiated recipi- 
ents. The parallel here between GVH and MLR results was not however abso- 
lute. In the GVH reaction the combination of spleen and LN cells in a ratio of 1496  SYNERGY  IN  THE  MIXED  LYMPHOCYTE  REACTION 
5:1  from irradiated reconstituted mice gave reactivity comparable to normal 
spleen  cells.  In  MLR,  while  reactivity  could  be  demonstrated  under  these 
conditions, it was substantially less than that of normal spleen cells. 
The major lesion produced by moderate doses of ATS involves the recirculat- 
ing lymphocytes (15,  16).  Itinerant-recirculating spleen lymphocytes (T2 cell) 
and residual sessile cells (T1 cell), which latter are relatively resistant to ATS, 
participate in  the  GVH response (2).  We found almost no loss of spleen cell 
reactivity  in  MLR  after  treatment  with  a  low  dose  of ATS,  while  LN-cell 
reactivities were markedly decreased  (Fig.  2).  By contrast,  a  higher  dose of 
ATS affected both tissues (Fig. 3). Thus, in the MLR two cell types can react, 
one derived from lymph nodes, which recirculates and is relatively sensitive to 
ATS, and a second or sessile type from spleens. A paradoxical effect of ATS on 
thymocytes was observed only when the higher  doses of ATS  (0.75  ml)  was 
used. 
We  could not  demonstrate  a  differential  effect of ATS  or of anti-0  serum 
upon the mixed lymphocyte reactivity and synergizing capability of LN cells, 
although  this had been shown  in  the  GVH reaction by Cantor and Asofsky 
(2, 4). 
Other  possible  differences  between  GVH and  MLR  models  can  be  mentioned. 
While in the GVH reaction a clear relationship exists between the response as meas- 
ured in the Simonsen assay and the logarithms of the cell doses in the range 0.5-20 X 
10  ~ cells/mouse (14), we observed in the range of 1-8 X  106 cells/ml in MLR a more 
or less linear relationship between [aH]thymidine uptake and numbers of responding 
cells. Above a certain cell concentration (about 12 ×  106 cells/ml), no further increase 
could be obtained under the conditions  of our test. Differences  in reaction times are 
also evident when the GVH reaction and MLR are compared. A measurable response 
in MLR is achieved by the 2nd day, while the GVH reaction usually requires a longer 
time (9 days in the experiments by Cantor and Asofsky). 
The GVH reaction is of course a far more complicated event (17) than the MLR. 
In the GVH reaction the recognition  of antigen by certain lymphocytes is followed by 
an inflammatory response by the host, by the transformation of reacting donor lympho- 
cytes into proliferating blasts, and  by damage to host  cells. The MLC reaction is 
considered  to be an in vitro model of merely the recognition  or first phase of the GVH 
reaction (18). Comparing the complexity of events involved respectively in the GVH 
reaction and MLR, it is not surprising  that some apparent differences might be found 
in  the behavior of the thymus-dependent subpopulations responsible  for both reac- 
tions. However, the similarities  are sufficient to suggest  that identical subpopulations 
may be involved. 
In a recent study using the cell-mediated lymphocytotoxic reaction against 
target  cells,  Wagner  (7)  noted  synergy between  thymocytes and  peripheral 
T cells, thus extending an earlier report by Cohen and Howe (6). Wagner found, 
however, that for cell-mediated cytotoxicity the thymus cells manifested mainly 
a helper (amplifying) activity, and that peripheral T  cells provided the major 
source for the precursor ceils of cytotoxic lymphocytes. This is in fact opposite W.  TITTOR, M.  GERBASE-DELIMA, AND  R.  L.  WALFORD  1497 
to the roles assigned for T1-T2-cell interaction in the GVH reaction. One notes 
that in the mouse the MLR is directed against so-called lymphocyte-defined 
(LD) antigens, or against LD plus serologically defined (SD) antigens, and the 
cytotoxic reaction only against SD antigens (7). Our own studies do not bear 
directly upon the question of which T-cell subpopulation is precursor, which 
amplifies, but do indicate that  all  the described parameters of synergy itself 
may be manifested during the recognition phase of the cellular immune reac- 
tion. 
SUMMARY 
The  present  studies  have  shown  that  two  subpopulations  of  thymus-de- 
pendent lymphocytes may act synergistically in the mixed lymphocyte reaction 
(MLR)  in  the mouse. One subpopulation was  well represented in  the young 
adult  thymus  and  the  other  in  lymph  nodes.  For  optimum  synergy,  both 
populations must be allogeneic to the stimulator cells.  Pretreatment of either 
population with mitomycin-C abolished synergy. Anti-O serum abolished both 
MLR responding and synergizing activities of lymphoid cells. The two thymus- 
dependent subpopulations were both present in the spleen, and displayed differ- 
ent migratory patterns when injected into irradiated mice: one population went 
to spleens of the irradiated mice, the other to lymph nodes. The effects of anti- 
thymocyte serum on the MLR and upon synergy were assessed. While minor 
differences exist and are herein described, our overall results strongly suggest 
that in our experiments with synergy in MLR,  we may be dealing with the 
same  T1-  and  T2-cell  subpopulations  described by  Cantor  and  Asofsky and 
coworkers (1,  2, 4, 5,  14) as displaying synergy in the graft-vs.-host reaction. 
We are indebted to Jess Peagler and Joyce Wilkinson for their technical assistance. 
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